Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
109 studies found for:    "familial dilated cardiomyopathy" OR "congestive cardiomyopathy" OR "familial idiopathic cardiomyopathy" OR "primary familial dilated cardiomyopathy" OR "Cardiomyopathy, Dilated"
Show Display Options
Rank Status Study
1 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention
2 Completed
Has Results
Coenzyme Q10 Supplementation in Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Coenzyme Q10;   Drug: Placebo
3 Terminated Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Drug: Rosiglitazone therapy
4 Unknown  Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: umbilical cord mesenchymal stem cells
5 Completed Intracoronary Infusion of Autologous Bone Marrow Cells for Treatment of Idiopathic Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Intracoronary infusion of autologous bone marrow cells
6 Completed Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Benazepril;   Drug: Valsartan;   Drug: Metoprolol
7 Completed Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: granulocyte colony stimulating factor (GCSF);   Procedure: bone marrow mononuclear cells
8 Recruiting Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Dilated Cardiomyopathy and Heart Failure.
Condition: Idiopathic Dilated Cardiomyopathy
Interventions: Drug: Infusion of autologous mononuclear bone marrow cells;   Drug: Placebo infusion
9 Completed Nesiritide - Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Drug: Nesiritide;   Drug: 5% Dextrose
10 Unknown  Cell Therapy In Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: Stem cell
11 Completed Use of Ixmyelocel-T (Formerly Cardiac Repair Cell [CRC] Treatment) in Patients With Heart Failure Due to Dilated Cardiomyopathy (IMPACT-DCM)
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
12 Completed Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Biological: Cardiac Repair Cells (CRCs)
13 Not yet recruiting Pathophysiology of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
14 Recruiting Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy
Conditions: Dilated Cardiomyopathy;   Chronic Heart Failure
Interventions: Procedure: Intramyocardial injection;   Procedure: Intracoronary injection
15 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
16 Unknown  Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Biological: CD34+ autologous stem cell transplantation;   Drug: Bone Marrow Stimulation
17 Recruiting PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors
Condition: Dilated Cardiomyopathy
Interventions: Drug: perindopril;   Drug: placebo
18 Recruiting PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study)
Condition: Non-ischemic Dilated Cardiomyopathy
Interventions: Procedure: Transendocardial injection;   Biological: Autologous hMSCs;   Biological: Allogeneic hMSCs
19 Recruiting 18F-deoxyglucose (FDG) PET-CMD
Condition: Patients With Idiopathic Dilated Cardiomyopathy
Intervention: Drug: 18F-deoxyglucose (FDG)
20 Unknown  Intracoronary Autologous Mesenchymal Stem Cells Implantation in Patients With Ischemic Dilated Cardiomyopathy
Condition: Ischemic Dilated Cardiomyopathy
Intervention: Other: Bone Marrow derived Mesenchymal Stem cells Implantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years